Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA approves OTC status for Elan's nicotine patch

Jan. 7, 1999

Selective inhibitor of neuronal dopamine transporter developed by U.S. university team

Jan. 4, 1999

Lilly develops novel 5-HT1A/5-HT1D antagonists for smoking cessation and CNS disorders

Dec. 23, 1998

SB launches smoking cessation line in European markets

Dec. 1, 1998

U.S. university researchers claim cocaine analogues for drug addiction, PD and depression

Nov. 27, 1998

Nicotinic acetylcholine receptor ligands for nicotine addiction and CNS disorders

Nov. 11, 1998

Apotex conducting early studies on oral chelating agents

Oct. 27, 1998

Animal studies provide further support for the role of dopaminergic systems in alcoholism

Oct. 26, 1998

Novel orally active iron chelator presented by Novartis researchers

Oct. 21, 1998

Nicotinic acetylcholine receptor ligands from Pfizer for addictive and CNS disorders

Oct. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026